Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06412874 · ClinicalTrials.gov registry record
Assessment of Supportive Care and Educational Needs to Guide Quality Care Improvements for Patients With Locally Advanced and Metastatic Bladder Cancer
A clinical trial of Screening Tool and Focus Group, sponsored by Icahn School of Medicine at Mount Sinai.
- Active
- Registry status
- 210
- Enrollment target
- 1
- Study location
NCT06412874: Active study of Screening Tool and Focus Group, sponsored by Icahn School of Medicine at Mount Sinai.
NCT06412874 is a study of Screening Tool and Focus Group that is active but no longer recruiting, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 210 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06412874, a study of Screening Tool and Focus Group, is active but no longer recruiting, sponsored by Icahn School of Medicine at Mount Sinai.
- ACTIVE NOT RECRUITING
- Registry status
- 210 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this study is to facilitate care improvements for bladder cancer patients with locally advanced or metastatic disease by designing and evaluating a patient need assessment screening tool to be used, in the future, as standard screening measure. Adult individuals diagnosed with Stage 4 incurable locally advanced or metastatic bladder cancer will be included in this study and asked to participate in a focus group, complete a screening tool, or complete a survey. All data collected will be linked to a study ID number and HIPAA identifiers will not be linked to study data. Identifying information (ie: name, mrn, email, phone number) will be utilized for study recruitment and identifying eligible patients. Any disclosure of the human subjects' responses outside the research would not reasonably place the subjects at risk of criminal or civil liability or be damaging to the subjects' financial standing, employability, educational advancement, or reputation.
Primary Outcome
The Bladder Cancer Need Assessment Survey (BCNAS) includes 8 subscales: psychological, informational, care and support, logistic, sexuality, physical and daily living, communication with providers; and communication with social partners/family All subscales scored 0-100. Full scale scored from 0- 100. Higher score mean higher levels of unmeet needs. This is a measure of unmet needs.
Conditions Studied
Interventions
- OTHER Screening tool
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2025-05-20 |
| Est. Completion | 2025-10-31 |
What the registry record for NCT06412874 still lists
NCT06412874 is an observational study that tracks outcomes without assigning an intervention. The registered 210 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Screening Tool appearing as the primary indexed condition, and to 1 intervention - of which Screening tool is the first listed.
NCT06412874 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06412874 about?
NCT06412874 is a clinical study titled "Assessment of Supportive Care and Educational Needs to Guide Quality Care Improvements for Patients With Locally Advanced and Metastatic Bladder Cancer". The overall goal of this study is to facilitate care improvements for bladder cancer patients with locally advanced or metastatic disease by designing and evaluating a patient need assessment screening tool to be used, in the future, as standard screening measure. Adult individuals diagnosed with St...
What is the current status of trial NCT06412874?
This trial is currently active not recruiting. The enrollment target is 210 participants. The study started on 2025-05-20. Estimated completion is 2025-10-31.
What conditions does trial NCT06412874 study?
This clinical trial studies the following conditions: Screening Tool, Focus Group.
What interventions are being tested in trial NCT06412874?
The interventions under investigation include: Screening tool (OTHER).
Who is sponsoring clinical trial NCT06412874?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06412874 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
- NCT03544489 · 210 participants · Phase 2
Effectiveness of Exercise After an ICD
- NCT04408430 · 210 participants · NA
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI